Intermittent fasting is an increasingly popular diet pattern of alternating eating and dieting.One particular form of intermittent fasting is the so-called time-restricted feeding (TRF). TRF allows for ad libitum feeding within a large window of time each day, and does not require any calorie counting. There is growing evidence that it can lose weight, reduce insulin resistance and improve cardiometabolic health. Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine and metabolic disease affecting women of childbearing age. PCOS shows anovulation or oligoovulation, hyperandrogenemia and ovarian polycystic changes. Insulin resistance and obesity are common features of PCOS. Whether the TRF impacts women with PCOS is still unknown due to the paucity of data in this area. To explore the effects of TRF on the endocrine and metabolic profile in overweight women with PCOS, a 6-week single-arm trial, divided into 2 consecutive periods: (1) 1-week baseline period; and (2) 5-week TRF period, will be implemented.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
18
The trial consists of a 1-week baseline weight stabilization period followed by a 5-week TRF intervention period. Participants will be instructed to eat freely from 8 a.m. to 4 p.m. daily and fast from 4 p.m. to 8 a.m. the next day.
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Insulin resistance
Will be assessed by homeostasis model assessment-insulin resistance (HOMA-IR)
Time frame: 5-week intervention period
Sex hormone-binding globulin (nmol/L)
Time frame: 5-week intervention period
Body Mass Index (BMI) (kg/m^2)
Weight (kg) and height (m) will be combined to report BMI
Time frame: 5-week intervention period
Waist-to-Hip Ratio (WHR)
Waist and hip will be combined to report WHR
Time frame: 5-week intervention period
Free androgen index (FAI) (%)
Time frame: 5-week intervention period
Total testosterone (TT) (ng/mL)
Time frame: 5-week intervention period
Area under the curve (AUC) for insulin
Insulin release test will be conducted
Time frame: 5-week intervention period
Area under the curve (AUC) for glucose
Glucose tolerance test will be conducted
Time frame: 5-week intervention period
Area under the curve (AUC) for insulin/Area under the curve (AUC) for glucose
Glucose tolerance test will be conducted
Time frame: 5-week intervention period
Fasting insulin (FINS) (mU/L)
Time frame: 5-week intervention period
Fasting blood glucose (FBG) (mmol/L)
Time frame: 5-week intervention period
Dietary behavior
Measured by the Three Factor Eating Questionnaire Revised 21 Item (TFEQ-R21) questionnaire
Time frame: 5-week intervention period
Time to return to normal menstrual cycle
Time frame: 5-week intervention period
Insulin-like growth factor 1 (IGF-1) (ng/mL)
Time frame: 5-week intervention period
Body fat (kg)
Measured by InBody, a body composition analyzer
Time frame: 5-week intervention period
Body fat percentage (%)
Measured by InBody, a body composition analyzer
Time frame: 5-week intervention period
Visceral fat area (cm^2)
Measured by InBody, a body composition analyzer
Time frame: 5-week intervention period
Skeletal muscle content (kg)
Measured by InBody, a body composition analyzer
Time frame: 5-week intervention period
High-sensitivity C-reactive protein (hs-CRP) (mg/L)
A kind of inflammatory biomarker
Time frame: 5-week intervention period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.